Literature DB >> 11603213

Partial hydatidiform mole: clinicopathological features, differential diagnosis, ploidy and molecular studies, and gold standards for diagnosis.

D R Genest1.   

Abstract

Partial hydatidiform mole is optimally diagnosed histopathologically when four microscopic features coexist: 1) two populations of villi, 2) enlarged villi (> or = 3-4 mm) with central captivation, 3) irregular villi with geographic, scalloped borders with trophoblast inclusions, and 4) trophoblast hyperplasia (usually focal and involving syncytiotrophoblast). Pathologic mimics of partial mole include Beckwith-Wiedemann syndrome, placental angiomatous malformation, twin gestation with complete mole and existing fetus, early complete hydatidiform mole, and hydropic spontaneous abortion. Because partial hydatidiform mole results from diandric triploidy, flow cytometry (or another method to assess ploidy) can be utilized by pathologists for supporting diagnostic classification of problematic specimens, or for educational or quality assurance purposes. Confirmation of the histopathologic diagnosis by ploidy or molecular studies is important for scientific reports of partial hydatidiform mole, especially when unusual or aggressive outcomes (such as choriocarcinoma) are reported.

Entities:  

Mesh:

Year:  2001        PMID: 11603213     DOI: 10.1097/00004347-200110000-00001

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  12 in total

1.  Abnormal villous morphology associated with triple trisomy of paternal origin.

Authors:  Alexis Norris-Kirby; Jill M Hagenkord; Malti P Kshirsagar; Brigitte M Ronnett; Kathleen M Murphy
Journal:  J Mol Diagn       Date:  2010-04-22       Impact factor: 5.568

2.  STR DNA genotyping of hydatidiform moles in South China.

Authors:  Xing-Zheng Zheng; Pei Hui; Bin Chang; Zhi-Bin Gao; Yan Li; Bing-Quan Wu; Bo Zhang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

3.  Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists.

Authors:  Mamta Gupta; Russell Vang; Anna V Yemelyanova; Robert J Kurman; Fanghong Rose Li; Emily C Maambo; Kathleen M Murphy; Cheryl DeScipio; Carol B Thompson; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2012-12       Impact factor: 6.394

4.  Derivation of human triploid trophoblast stem cells.

Authors:  Xuhui Kong; Xin Chen; Songbang Ou; Wenjun Wang; Ruiqi Li
Journal:  J Assist Reprod Genet       Date:  2022-05       Impact factor: 3.357

5.  [Gestational trophoblastic disease, Villous gestational trophoblastic disease].

Authors:  M Vogel; L-C Horn
Journal:  Pathologe       Date:  2004-07       Impact factor: 1.011

Review 6.  Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine.

Authors:  Natalia Buza; Pei Hui
Journal:  Mod Pathol       Date:  2021-06-04       Impact factor: 7.842

7.  Combination of immunohistochemistry and ploidy analysis to assist histopathological diagnosis of molar diseases.

Authors:  M C Osterheld; L Caron; P Chaubert; K Meagher-Villemure
Journal:  Clin Med Pathol       Date:  2008-03-19

8.  Diagnostic value of P63 in differentiating normal gestation from molar pregnancy.

Authors:  Mitra Heidarpour; Marzieh Khanahmadi
Journal:  J Res Med Sci       Date:  2013-06       Impact factor: 1.852

9.  Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases.

Authors:  Deyin Xing; Emily Adams; Jialing Huang; Brigitte M Ronnett
Journal:  Mod Pathol       Date:  2020-10-06       Impact factor: 7.842

10.  Flow Cytometric DNA Analysis and Histopathologic Re-Evaluation of Paraffin Embedded Samples from Hydatidiform Moles and Hydropic Abortions.

Authors:  Narges Izadi-Mood; Soheila Sarmadi; Reza Tayebivaljozi; Farzaneh Mohammadi-Zia; Mohammad Farhadi
Journal:  Int J Fertil Steril       Date:  2015-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.